The efficacy of metoclopramide in the treatment of migraine headache

      This paper is only available as a PDF. To read, Please Download here.

      Study objectives:

      By evaluating the efficacy of metoclopramide alone and in combination with ibuprofen versus placebos, this study was designed to both evaluate the efficacy of metoclopramide and elucidate its mechanism of action in the treatment of migraine headache.


      The study was conducted over a two-year period and was a randomized, double-blind, placebo-controlled study.


      An urban teaching hospital.


      Patients enrolled were at least 18 years old and had recurring headaches with one or more of the following characteristics: unilateral, preceded by neurologic symptoms, significant nausea and vomiting, or mood changes and photophobia.


      Ten milligrams of metoclopramide or an equal volume of IV normal saline was given and 600 mg of ibuprofen or identical-appearing placebo was given orally at time 0. Patients rated their pain and nausea at time 0, 30 minutes, and 60 minutes using visual-analog scales.


      The differences in pain and nausea scores for the metoclopramide + placebos group versus the other three groups were tested using exact nonparametric (Mann-Whitney) statistical procedures. The metoclopramide + placebos group had significantly better relief of pain compared with the placebos + ibuprofen and placebos + placebos groups. The metoclopramide + placebos group had significantly better relief of nausea than the ibuprofen + placebos group; nausea scores for the placebos + placebos group could not be analyzed due to excessive variance from the other groups at baseline. The differences between the metoclopramide + placebos group and the metoclopramide + ibuprofen group were not statistically significant with regard to either pain or nausea.


      Metoclopramide is efficacious in the treatment of both the pain and nausea of migraine headache. This is a direct action that is not dependent on the concomitant administration of another agent.
      To read this article in full you will need to make a payment
      ACEP Member Login
      ACEP Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Edmeads JG
        Migraine: Recent advances in pharmacotherapy.
        CMAJ. 1988; 138: 107-113
        • Volans GN
        Research review migraine and drug absorption.
        Clin Pharmacokinet. 1978; 3: 313-318
        • Diamond S
        • Freitag FG
        Do non-steroidal anti-inflammatory agents have a role in the treatment of migraine headaches?.
        Drugs. 1989; 37: 755-760
        • Havanka-Kanniainen H
        Treatment of acute migraine attack: Ibuprofen and placebo compared.
        Headache. 1989; 29: 507-509
        • Hughes JB
        Metoclopramide in migraine treatment.
        Med J Austr. 1977; 2: 580
        • Iserson KV
        Parenteral chlorpromazine treatment of migraine.
        Ann Emerg Med. 1983; 12: 756-763
        • Lane PL
        • McClellan BY
        • Baggoley CJ
        Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache.
        Ann Emerg Med. 1989; 18: 360-365
        • Bell R
        • Montoya D
        • Shuaib A
        • et al.
        A comparative trial of three agents in the treatment of acute migraine headache.
        Ann Emerg Med. 1990; 19: 1079-1082
        • Barclay CL
        • Shuaib MD
        • Montoya MD
        • et al.
        Response of non-migrainous headaches to chlorpromazine.
        Headache. 1990; 30: 85-87
        • Tek DS
        • McClellan DS
        • Olshaker JS
        • et al.
        A prospective double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department.
        Ann Emerg Med. 1990; 19: 1083-1087